NCT05482568 2023-10-16
A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2 Unknown
Jiangsu HengRui Medicine Co., Ltd.
Hangzhou ACEA Pharmaceutical Research Co., Ltd.